-
Real-world Outcomes in Multiple Myeloma
Study shines a light on the differences in outcomes between clinical trial patients with multiple myeloma and those receiving cancer treatment in their community.
by Sandra Gordon
-
January 26: The Week in Cancer News
Questions about screening for women with dense breast tissue, and the FDA asks drugmakers to add a warning to labels for CAR T-cell therapies.
by Thomas Celona
-
Some Breast Cancer Patients May Safely Skip Radiation
Three presentations at SABCS in December find that it may be safe in certain cases for people with breast cancer to go without radiation.
by Cancer Research Catalyst
-
January 19: The Week in Cancer News
Preventive gastrectomy has lasting effects, and rising cancer incidence undercuts continued progress against mortality.
by Eric Fitzsimmons
-
January 12: The Week in Cancer News
Hiding serious illness can be a coping strategy, and cancer rates are on the rise among young people.
by Kevin McLaughlin
-
Doctors Urge Need for ‘Common Sense Oncology’
A movement of health care professionals say the toll of many cancer treatments is out of sync with the purported benefits.
by Kyle Bagenstose
-
January 5: The Week in Cancer News
The FDA will review a blood test that detects colon cancer, and a writer recounts his sister’s decision to receive medical aid in dying.
by Marci A. Landsmann
Previous |
Cancer Talk
Can Steroids Impair Immunotherapy for Cancer?
A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles
Technology’s Changing Role in Cancer CareExperts explain how artificial intelligence, nanotechnology and decentralized care are poised to improve research, detection and treatment.
by Thomas Celona